News
-
-
-
-
-
-
PRESS RELEASE
EQS-Adhoc: Biotest AG: CFO Martin Möller to leave Biotest as planned at the end of his contract. Position of CFO to be filled in the near future.
Biotest AG announces CFO Martin Moller's planned departure at end of contract, search for successor initiated. Moller to provide advisory support post-contract -
-
-
-
PRESS RELEASE
Important milestone for Biotest: Biologics License Application for Fibrinogen submitted to the US Food and Drug Administration (FDA)
Biotest AG reaches a significant milestone by submitting a Biologics License Application for Fibrinogen to the US FDA, aiming to address fibrinogen deficiency
